Aptose Corporate Presentation July 2022

Jul 19, 2022

Aptose Corporate Presentation June 2022

Jun 27, 2022

2022 EHA Poster - Myeloid Kinome Inhibitor HM43239 Overcomes Acquired Resistance in Acute Myeloid Leukemia Models

Jun 10, 2022

Aptose KOL Event and Clinical Update

Jun 2, 2022

Aptose Corporate Presentation March 2022

Mar 15, 2022

Aptose Corporate Update at ASH 2021

Dec 13, 2021

2021 ASH Poster - A Phase 1a/b Study of APTO-253 in R/R AML and HR-MDS

Dec 13, 2021

2021 ASH Presentation - A Phase 1/2 Study of HM43239 in R/R AML

Dec 13, 2021

2021 ASH Poster - A Phase 1a/b Dose Escalation Study of Luxeptinib in R/R AML

Dec 11, 2021

2021 ASH Poster - A Phase 1a/b Dose Escalation Study of Luxeptinib in R/R B-Cell Malignancies

Dec 11, 2021

• « Previous
• 1
• 2
• 3
• 4
• 5
• 6
• Next »